Feldamycin

Class: Aminoglycoside

Spectrum of activity:	Gram-negative
Details of activity:	DNA Synthesis inhibitor
Institute where first reported:	The UpJohn Company
Year first mentioned:	1976
Highest developmental phase:	Preclinical
Development status:	Inactive
Reason Dropped:	"lack of clinical promise"

Chemical structure(s):
Canonical SMILES:	CC(C(C(=O)O)NC(=O)C(CC1=CN=CN1)NC)NC(CC2=CN=CN2)C(=O)O
Isomeric SMILES:	CC(C(C(=O)O)NC(=O)C(CC1=CN=CN1)NC)NC(CC2=CN=CN2)C(=O)O
InChI:	InChI=1S/C17H25N7O5/c1-9(23-13(16(26)27)4-11-6-20-8-22-11)14(17(28)29)24-15(25)12(18-2)3-10-5-19-7-21-10/h5-9,12-14,18,23H,3-4H2,1-2H3,(H,19,21)(H,20,22)(H,24,25)(H,26,27)(H,28,29)
InChI Key:	LUOBEJSTJAVJPL-UHFFFAOYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/10409115

External links:
Guide to Pharmacology:	feldamycin
Citation:	https://www.ncbi.nlm.nih.gov/pubmed/994320